Product Information
MELOXICAM 7.5 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0165 per EA under NDC 69097015812. Its NADAC has been published 604 times since Jan 28, 2015.
FDA first approved this application on Jul 19, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Cipla USA Inc.NDC
69097015812
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MELOXICAMApproval Type
Generic (ANDA)
FDA Application
ANDA077929FDA Approved
7/19/2006
TE Code
AB
On Market Since
7/19/2006
Pharmacological Classes
Price Statistics
The NADAC for MELOXICAM 7.5 MG TABLET has been published 604 times since Jan 28, 2015, and over the history we have for it it has declined 30.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0165 per EA |
|---|---|
| All-time high | $0.0255 (Apr 15, 2015) |
| All-time low | $0.0138 (Nov 20, 2024) |
| 52-week high | $0.0174 |
| 52-week low | $0.0164 |
| Median price | $0.0194 |
| Average price | $0.0197 |
| Largest weekly change | +26.2% (Aug 21, 2024) |
| Weeks tracked | 604 |
| Tracking since | Jan 28, 2015 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MELOXICAM 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MELOXICAM 7.5 MG TABLET, manufactured by Cipla USA Inc., is $0.0165 per EA (NDC 69097015812), effective Aug 19, 2026.
How has the price of MELOXICAM 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MELOXICAM 7.5 MG TABLET has declined 30.6%. It has been tracked across 604 weekly CMS publications since Jan 28, 2015.
What are the highest and lowest recorded NADAC prices for MELOXICAM 7.5 MG TABLET?
Since Jan 28, 2015, the NADAC for MELOXICAM 7.5 MG TABLET has ranged from a low of $0.0138 (Nov 20, 2024) to a high of $0.0255 (Apr 15, 2015), with a median of $0.0194 per EA.
Are there cheaper alternatives to MELOXICAM 7.5 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MELOXICAM 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MELOXICAM 7.5 MG TABLET?
MELOXICAM 7.5 MG TABLET (NDC 69097015812) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.